Logo
x

Search

Subscribe Now

Abbisko Therapeutics

Abbisko Therapeutics’ Pimicotinib (ABSK021) Receives US FDA’s Fast Track Designation for Treating Tenosynovial Giant Cell Tumor

Abbisko Therapeutics’ Pimicotinib (ABSK021) Receives US FDA’s Fast Track Designation for Treating Tenosynovial Giant Cell Tumor

  • December 14, 2023
Abbisko Therapeutics Reports the Completion of First Patient Dosing of ABSK061 in P-I (ABSK061-101) Clinical Trial for the Treatment of Solid Tumors

Abbisko Therapeutics Reports the Completion of First Patient Dosing of ABSK061 in P-I (ABSK061-101) Clinical Trial for the Treatme...

  • July 4, 2022
Image

Incisive News in 3 Shots.

Contact Us

Our Information

Follow Us

Copyright © 2024 PharmaShots - All Rights Reserved.